E. Fireman (Tel-Aviv, Israel), T. Peros Golubicic (Zagreb, Croatia)
New therapy for pulmonary-renal Goodpasture‘s syndrome
A. Demin (Novosibirsk, Russian Federation)
|   |
Coexistent pulmonary emphysema delays the decrease in vital capacity in patients with idiopathic pulmonary fibrosis
T. Akagi, T. Matsumoto, R. Aramaki, C. Yoshimura, T. Kuraki, H. Toyoshima, M. Fujita, K. Watanabe (Fukuoka, Japan)
| |
Hypersensitivity pneumonitis: diagnostic mistakes
D. Stupachenko, O. Semendyayeva, A. Visotskiy, N. Monogarova (Donetsk, Ukraine)
| |
Non-infectious pulmonary involvement in myelodysplastic syndrome
K. Umeki, H. Ishii, A. Iwata, R. Shirai, K. Kishi, I. Tokimatsu, M. Ogata, J. I. Kadota (Yufu-city/Oita, Japan)
| |
Depiction of malignancy in patients with diffuse interstitial lung disease (DILD) presenting with nodular opacities
R. Triggidou, F. P. Kokkinis, I. Tsangaridou, P. Tsagouli, K. Pottaris, K. Malagari, L. Thanos, M. A. Dimadi (Athens, Lamia, Greece)
| |
Chemokine receptors in a regulation of interstitial lung fibrosis and inflammation
M. Sterclova, M. Vasakova, M. Metlicka, J. Pavlicek, I. Striz (Prague, Czech Republic)
| |
Difference in accuracy of interstitial lung disease HRCT interpretation between radiologists with and without a specialist interest in thoracic radiology
R. Heinink, B. Holloway, S. Trotter, M. Djearaman, J. Reynolds, S. Burge (Birmingham, United Kingdom)
| |
De novo interstitial fibrosis after pulmonary resection
K. Kant, M. Grootenboers (Breda, Netherlands)
| |
Analysis of BAL and clinical-radiologic features of a population of PLCH
E. Bargagli, M. Abbritti, R. M. Refini, M. A. Mazzei, P. Rottoli (Siena, Italy)
| |
BAL cytology in pulmonary alveolar proteinosis: a review of 7 cases
I. Papanikolaou, K. Tsakanika, V. Skouras, N. Karagianidis, V. Polychronopoulos, M. Kokosi, D. Mermigkis, E. Papageorgiou (Athens, Attiki, Greece)
| |
A case with pulmonary histiocytosis X and lung cancer
B. Uskul, F. Turan, O. Bayraktar, O. Celenk, F. Aksoy, H. Turker (Istanbul, Turkey)
| |
Pulmonary Langerhans‘ cell histiocytosis (PLCH). Report of two cases diagnosed with pulmonary vascular involvement via exercise tests
A. Yilmaz, S. Akpinar, G. E. Ayten, Y. Erdogan, U. Yilmaz Turay, L. Yilmaz Aydin, B. Ciftci, C. Biber, P. Ergun, S. Sahin (Ankara, Turkey)
| |
Are lung biopsy and steroid treatment mandatory for cryptogenic organizing pneumonia with typical radiographic presentation such as ²reversed halo sign² on CT-scan?
B. Godbert, C. Clément-Duchêne, A. D. Paoli, S. Corhut, D. Braun, D. Régent, Y. Martinet (Vandoeuvre-lès-Nancy, Briey, France)
| |
Lung cancer in patients with cryptogenic fibrosing alveolitis
J. Homolka, M. Pesek, L. Svobodova, R. Bittenglova (Prague, Pilsen, Czech Republic)
| |
Estimation of antibiotic effect on the development of bleomycin-induced pulmonary fibrosis
L. Novikova, E. Lebedeva, L. Danilov, I. Dvorakovskaya (St.Petersburg, Russian Federation)
| |
Differences in the immunolocalization of surfactant protein (SP)-A, SP-D and KL-6 in pulmonary alveolar proteinosis
M. Kobayashi, S. Hirose, A. Murata, N. Morishita, T. Kitagawa, Y. Ohtsuki (Kochi, Matusyama, Japan)
| |
Baseline characteristics of the Italian cohort of patients affected by pulmonary alveolar proteinosis (PAP)
Z. Kadija, I. Campo, G. Rodi, F. Mariani, A. Corsico, P. Ernesto, M. Luisetti (Pavia, Italy)
| |
Clinical presentation and outcome of fibrosing mediastinitis
T. Peikert, T. Colby, D. Midthun, E. Edell, U. Specks (Rochester, MN, Scottsdale, AZ, United States Of America)
| |